Requiring manufacturers to demonstrate the stability of their scored tablets after 90 days seemed logical, but advisory committee members appeared to question the usefulness of the data for patients.
FDA wants the study to show under essentially ideal conditions – 25 degrees Celsius and 60% relative humidity – that the split tablets remain stable.
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Pink Sheet for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?